Crossmark

Hydrophilic Stent Coating Inhibits Platelet Adhesion on Stent Surfaces: Initial Results In Vitro

Crossref DOI link: https://doi.org/10.1007/s00270-018-2036-7

Published Online: 2018-07-23

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lenz-Habijan, Tim

Bhogal, P. https://orcid.org/0000-0002-5514-5237
Peters, Marcus

Bufe, Albrecht

Martinez Moreno, Rosa

Bannewitz, Catrin

Monstadt, Hermann

Henkes, Hans
License Information

Text and Data Mining valid from 2018-07-23
More Information

Article History

Received: 5 March 2018

Accepted: 20 May 2018

First Online: 23 July 2018

Compliance with Ethical Standards

:

: TLH is employed in the R&D department of phenox. PB is a consultant and proctor for phenox and Neurvana Medical. MP, AB declared no conflict of interests. RMM is a consultant and proctor for phenox. HH is a co-founder and shareholder of phenox. HM is a co-founder, shareholder and CEO of phenox.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.